• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性冠状动脉疾病初始侵入性策略与保守策略后的心绞痛轨迹

Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease.

作者信息

Ikemura Nobuhiro, Jones Philip G, Fu Zhuxuan, Chan Paul S, Sherrod Charles F, Arnold Suzanne V, Cohen David J, Mark Daniel B, Maron David J, Hochman Judith S, Spertus John A

机构信息

Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, Missouri, USA; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan; Department of Internal Medicine, Tachikawa Hospital, Tachikawa, Japan.

Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, Missouri, USA.

出版信息

J Am Coll Cardiol. 2025 Sep 16;86(11):782-793. doi: 10.1016/j.jacc.2025.06.044.

DOI:10.1016/j.jacc.2025.06.044
PMID:40930615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12492302/
Abstract

BACKGROUND

Clinical trials typically report average health status outcomes by treatment at single points in time, as opposed to participants' trajectories (or journeys) over time. Although ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) demonstrated better mean health status at discrete times with an invasive treatment among those with baseline angina, the patterns of individual participants' angina over time are unknown.

OBJECTIVES

The purpose of this study was to identify patterns of individual participants' angina over time after invasive or conservative management strategies for chronic coronary disease.

METHODS

In this secondary analysis of the ISCHEMIA trial, which enrolled participants with chronic coronary disease and moderate to severe ischemia from July 2012 to January 2018, we used ordinal latent trajectory analysis to assess angina frequency over a 2-year period, separately for participants assigned to the initial invasive and initial conservative arms. Angina frequency was defined using the SAQ-AF (Seattle Angina Questionnaire Angina Frequency) score, recategorized as daily/weekly (0-60 points), monthly (61-99 points), and no angina (100 points). Participants without baseline angina were excluded.

RESULTS

Among 2,977 participants with baseline angina, 1,505 (50.6%) were randomized to initial invasive and 1,472 (49.4%) to initial conservative management; baseline characteristics were well balanced between groups. Six distinct patterns of angina trajectories were identified in each arm and were qualitatively similar: 1) rapid resolution; 2) gradual resolution; 3) early improvement with persistent infrequent angina; 4) severe angina with improvement; 5) modest angina with minimal change; and 6) severe angina without improvement. In the invasive group, the most common patterns included rapid resolution (27.1%) and early improvement with persistent infrequent angina (32.1%), whereas the conservative group more often showed modest angina with minimal change (42.1%) and fewer cases of rapid resolution (12.8%) or early improvement with persistent infrequent angina (10.2%).

CONCLUSIONS

Patients with chronic coronary disease and angina experienced diverse symptom trajectories, ranging from rapid resolution to severe or persistent angina. A greater proportion of conservatively managed patients experienced unfavorable angina patterns over 2 years compared with those treated invasively. When health status is monitored over time, such patterns may help identify patients with persistent symptoms who could benefit from additional therapy. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).

摘要

背景

临床试验通常报告在单个时间点的治疗平均健康状况结果,而非参与者随时间的轨迹(或历程)。尽管缺血性心脏病比较医疗与侵入性治疗对健康影响的国际研究(ISCHEMIA)显示,在有基线心绞痛的患者中,侵入性治疗在离散时间点的平均健康状况更好,但个体参与者心绞痛随时间的模式尚不清楚。

目的

本研究的目的是确定慢性冠状动脉疾病采用侵入性或保守管理策略后,个体参与者心绞痛随时间的模式。

方法

在ISCHEMIA试验的这项二次分析中,该试验于2012年7月至2018年1月纳入了患有慢性冠状动脉疾病和中度至重度缺血的参与者,我们使用有序潜在轨迹分析来评估2年期间的心绞痛频率,分别针对分配到初始侵入性和初始保守治疗组的参与者。心绞痛频率使用西雅图心绞痛问卷心绞痛频率(SAQ - AF)评分定义,重新分类为每日/每周(0 - 60分)、每月(61 - 99分)和无心绞痛(100分)。排除无基线心绞痛的参与者。

结果

在2977例有基线心绞痛的参与者中,1505例(50.6%)被随机分配至初始侵入性治疗组,1472例(49.4%)被随机分配至初始保守治疗组;两组基线特征均衡。在每组中均识别出六种不同的心绞痛轨迹模式,且在性质上相似:1)快速缓解;2)逐渐缓解;3)早期改善但仍有偶尔心绞痛;4)严重心绞痛且有改善;5)轻度心绞痛且变化极小;6)严重心绞痛且无改善。在侵入性治疗组中,最常见的模式包括快速缓解(27.1%)和早期改善但仍有偶尔心绞痛(32.1%),而保守治疗组更常表现为轻度心绞痛且变化极小(42.1%),快速缓解(12.8%)或早期改善但仍有偶尔心绞痛(10.2%)的病例较少。

结论

患有慢性冠状动脉疾病和心绞痛的患者经历了从快速缓解到严重或持续性心绞痛的多种症状轨迹。与接受侵入性治疗的患者相比,更大比例的接受保守治疗的患者在2年期间经历了不良的心绞痛模式。当随时间监测健康状况时,这些模式可能有助于识别可能从额外治疗中获益的有持续症状的患者。(缺血性心脏病比较医疗与侵入性治疗对健康影响的国际研究[ISCHEMIA];NCT01471522)

相似文献

1
Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease.慢性冠状动脉疾病初始侵入性策略与保守策略后的心绞痛轨迹
J Am Coll Cardiol. 2025 Sep 16;86(11):782-793. doi: 10.1016/j.jacc.2025.06.044.
2
Vesicoureteral Reflux膀胱输尿管反流
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial.国际上在接受初始侵入性与保守性治疗的慢性冠状动脉疾病患者的健康状况获益方面存在差异:来自 ISCHEMIA 试验的见解。
Circ Cardiovasc Qual Outcomes. 2024 Oct;17(10):e010534. doi: 10.1161/CIRCOUTCOMES.123.010534. Epub 2024 Sep 20.
5
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.缺血性心脏病中经皮冠状动脉介入治疗和冠状动脉旁路移植术的健康状况结局
Circulation. 2025 Sep 23;152(12):846-858. doi: 10.1161/CIRCULATIONAHA.125.073591. Epub 2025 Sep 5.
6
Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.慢性冠状动脉疾病的有创与保守管理对健康状况的影响存在差异。
J Am Coll Cardiol. 2024 Apr 16;83(15):1353-1366. doi: 10.1016/j.jacc.2024.02.019.
7
Mid Forehead Brow Lift额中眉提升术
8
Incidence, Predictors, and Outcomes of Complete Angina Relief in Symptomatic Patients in the ISCHEMIA Trial.缺血性心脏病改善症状与认知治疗(ISCHEMIA)试验中症状性患者完全性心绞痛缓解的发生率、预测因素及结果
J Am Heart Assoc. 2025 Jun 17;14(12):e040057. doi: 10.1161/JAHA.124.040057. Epub 2025 Jun 5.
9
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.利用来自缺血性心脏病优化药物治疗与血管重建比较有效性研究(ISCHEMIA试验)的随机数据评估稳定型缺血性心脏病冠状动脉血运重建的适宜使用标准。
Circ Cardiovasc Qual Outcomes. 2025 Mar;18(3):e010849. doi: 10.1161/CIRCOUTCOMES.124.010849. Epub 2025 Feb 26.
10
Shoulder Arthrogram肩关节造影

本文引用的文献

1
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021年美国心脏病学会/美国心脏协会/心血管造影和介入学会冠状动脉血运重建指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.
2
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Nov 30;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28.
3
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.冠状动脉微血管功能障碍在心血管疾病谱中的表现:美国心脏病学会最新综述。
J Am Coll Cardiol. 2021 Sep 28;78(13):1352-1371. doi: 10.1016/j.jacc.2021.07.042.
4
Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care: A Review.西雅图心绞痛问卷解读作为临床试验和临床护理中的结局指标:综述。
JAMA Cardiol. 2021 May 1;6(5):593-599. doi: 10.1001/jamacardio.2020.7478.
5
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review.解读堪萨斯城心肌病问卷在临床试验和临床护理中的应用:美国心脏病学会最新综述
J Am Coll Cardiol. 2020 Nov 17;76(20):2379-2390. doi: 10.1016/j.jacc.2020.09.542.
6
Initial Invasive or Conservative Strategy for Stable Coronary Disease.稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
7
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.冠心病患者采用侵入性或保守治疗的健康状况结局。
N Engl J Med. 2020 Apr 9;382(15):1408-1419. doi: 10.1056/NEJMoa1916370. Epub 2020 Mar 30.
8
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.性别与中度或重度缺血患者的冠状动脉疾病严重程度、缺血和症状负担的关系:ISCHEMIA 随机临床试验的二次分析。
JAMA Cardiol. 2020 Jul 1;5(7):773-786. doi: 10.1001/jamacardio.2020.0822.
9
Framework to construct and interpret latent class trajectory modelling.构建和解释潜在类别轨迹模型的框架。
BMJ Open. 2018 Jul 7;8(7):e020683. doi: 10.1136/bmjopen-2017-020683.
10
Trajectories of Health-Related Quality of Life in Coronary Artery Disease.冠状动脉疾病中与健康相关的生活质量轨迹
Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e003661. doi: 10.1161/CIRCOUTCOMES.117.003661.